Researchers from the University of Zurich have discovered that thanatin, a compound produced naturally by the spined soldier bug, could target Gram-negative bacteria by preventing formation of the bacteria’s outer membrane – an unprecedented mechanism.
Browsing: Disease Area > Bacterial
Glenn Tillotson gives us an overview of the CDiff Foundation’s 6th annual educational meeting, including updates on new C. difficile IDSA/SHEA clinical guidelines and patient perspectives.
Take a look at our page for World Antibiotic Awareness Week, including some of our top content from the year, exclusive opinion pieces and a compilation of our #TalkAMR videos!
By carefully considering the characteristics of certain old and new antibiotics, it may be possible to overcome many bacterial resistance mechanisms, including when more than one is present.
A Phase II, muti-center, randomized, open-label trial has reported that a novel oral antibiotic, zoliflodacin, is effective in the treatment of uncomplicated urogenital gonorrhea.
A new study from the ECDC has estimated that 33,000 individuals die each year as a consequence of infections with antibiotic-resistant bacteria.
In this article, the authors discuss their research using non-ribosome targeting tobramycin-based adjuvants to overcome the intrinsic resistance observed in bacteria, Pseudomonas aeruginosa.
New data analysis of three clinical trials has suggested that a precision medicine approach could allow some pulmonary TB patients to have significantly shorter treatment periods.
In recent years, researchers have discovered the potential of CRISPR as an antimicrobial. In this blog post we explain the recent advances made in this field and the different approaches by which CRISPR can be used as a new weapon in the battle against antimicrobial resistance.